227 related articles for article (PubMed ID: 28278074)
21. Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients.
Xu PP; Wang Y; Shen Y; Wang L; Shen ZX; Zhao WL
Med Oncol; 2012 Sep; 29(3):2176-82. PubMed ID: 21710236
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study.
Li YJ; Yi PY; Li JW; Liu XL; Tang T; Zhang PY; Jiang WQ
Chin J Cancer; 2017 Jul; 36(1):62. PubMed ID: 28756771
[TBL] [Abstract][Full Text] [Related]
23. The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage.
Zeng L; Huang W; Cao Z; Zheng B; Liu X; Guo L; Feng X
Ann Hematol; 2019 Jun; 98(6):1467-1476. PubMed ID: 30895352
[TBL] [Abstract][Full Text] [Related]
24. A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type.
Wang KF; Chang BY; Chen XQ; Liu PP; Wuxiao ZJ; Wang ZH; Li S; Jiang WQ; Xia ZJ
Med Oncol; 2014 Dec; 31(12):318. PubMed ID: 25377661
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China.
Li F; Yang Y; Jin F; Dehoedt C; Rao J; Zhou Y; Li P; Yang G; Wang M; Zhang R; Yang Y
Orphanet J Rare Dis; 2015 Feb; 10():20. PubMed ID: 25757854
[TBL] [Abstract][Full Text] [Related]
26. Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome.
Han AR; Lee HR; Park BB; Hwang IG; Park S; Lee SC; Kim K; Lim HY; Ko YH; Kim SH; Kim WS
Ann Hematol; 2007 Jul; 86(7):493-8. PubMed ID: 17347847
[TBL] [Abstract][Full Text] [Related]
27. The role of Skp2 in extranodal NK/T-cell lymphoma.
Guo HQ; Pu XX; Guo CC; Rao HL; Li HR; Lin TY
Chin J Cancer; 2010 May; 29(5):567-71. PubMed ID: 20426910
[TBL] [Abstract][Full Text] [Related]
28. An effective diagnostic index for lymphoma-associated hemophagocytic syndrome.
Xie M; Li L; Zhu L; Zhou D; Yang X; Sun J; Zhu J; Zhu M; Zheng Y; Xie W; Ye X
QJM; 2018 Aug; 111(8):541-547. PubMed ID: 29800321
[TBL] [Abstract][Full Text] [Related]
29. When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?
Kim SJ; Oh SY; Hong JY; Chang MH; Lee DH; Huh J; Ko YH; Ahn YC; Kim HJ; Suh C; Kim K; Kim WS
Ann Oncol; 2010 May; 21(5):1058-63. PubMed ID: 19850636
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma.
Li N; Zhang L; Song HL; Zhang J; Weng HW; Zou LQ
Tumour Biol; 2017 May; 39(5):1010428317705503. PubMed ID: 28475009
[TBL] [Abstract][Full Text] [Related]
31. Clinical Characteristics of Hemophagocytic Lymphohistiocytosis Associated with Non-Hodgkin B-Cell Lymphoma: A Multicenter Retrospective Study.
Li B; Guo J; Li T; Gu J; Zeng C; Xiao M; Zhang W; Li Q; Zhou J; Zhou X
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e198-e205. PubMed ID: 33303420
[TBL] [Abstract][Full Text] [Related]
32. [Clinical characteristics and prognostic analysis of advanced-stage extranodal NK/T cell lymphoma].
Wei C; Zhang Y; Wang W; Zhang L; Zhang W; Zhou DB
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):462-468. PubMed ID: 32654458
[No Abstract] [Full Text] [Related]
33. Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome.
Zhou L; Liu Y; Wen Z; Yang S; Li M; Zhu Q; Qiu S; Gao Y; Wang H; Yuan Y; Zhang H; Chen C; Zeng W; Guan Z; Pan X
J Cancer Res Clin Oncol; 2020 Nov; 146(11):3063-3074. PubMed ID: 32617699
[TBL] [Abstract][Full Text] [Related]
34. Sintilimab combined with chidamide in the treatment of extranodal nature killer/T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis: Two case reports and literature review.
Xu QY; Yang HY; Li MW; He ZD; Hong HY; Peng ZG
Medicine (Baltimore); 2022 Sep; 101(38):e30731. PubMed ID: 36197207
[TBL] [Abstract][Full Text] [Related]
35. A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma.
Takahashi N; Miura I; Chubachi A; Miura AB; Nakamura S
Int J Hematol; 2001 Oct; 74(3):303-8. PubMed ID: 11721967
[TBL] [Abstract][Full Text] [Related]
36. Serum IL18 is associated with hemophagocytosis and poor survival in extranodal natural killer/T-cell lymphoma.
Lim SW; Ryu KJ; Lee H; Ko YH; Kim WS; Kim SJ
Leuk Lymphoma; 2019 Feb; 60(2):317-325. PubMed ID: 29979096
[TBL] [Abstract][Full Text] [Related]
37. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
38. Lymphoma associated hemophagocytic syndrome: A single-center retrospective study.
Chang Y; Cui M; Fu X; Han L; Zhang L; Li L; Li X; Sun Z; Wu J; Zhang X; Li Z; Nan F; Yan J; Sheng G; Zhang M
Oncol Lett; 2018 Jul; 16(1):1275-1284. PubMed ID: 30061947
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.
Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C
Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948
[TBL] [Abstract][Full Text] [Related]
40. [Lymphoma-associated hemophagocytic syndrome in Japan].
Takahashi N; Chubachi A; Miura I; Nakamura S; Miura AB
Rinsho Ketsueki; 1999 Jul; 40(7):542-9. PubMed ID: 10483136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]